Proteins > Telomerase reverse transcriptase
Page last updated: 2024-08-07 15:22:04
Telomerase reverse transcriptase
A telomerase reverse transcriptase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14746]
Synonyms
EC 2.7.7.49;
HEST2;
Telomerase catalytic subunit;
Telomerase-associated protein 2;
TP2
Research
Bioassay Publications (41)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (34.15) | 29.6817 |
2010's | 22 (53.66) | 24.3611 |
2020's | 5 (12.20) | 2.80 |
Compounds (28)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
7,8-dihydroxyflavone | Homo sapiens (human) | IC50 | 36.0000 | 1 | 1 |
ethacridine | Homo sapiens (human) | IC50 | 8.2000 | 3 | 3 |
berberine | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
9,10-phenanthrenequinone | Homo sapiens (human) | IC50 | 2.7500 | 2 | 2 |
ethidium bromide | Homo sapiens (human) | IC50 | 2.5900 | 13 | 13 |
camptothecin | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
staurosporine | Homo sapiens (human) | IC50 | 6.9517 | 6 | 6 |
acridine orange | Homo sapiens (human) | IC50 | 12.2000 | 3 | 3 |
epigallocatechin gallate | Homo sapiens (human) | IC50 | 1.0867 | 3 | 3 |
meridine | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
cryptolepine | Homo sapiens (human) | IC50 | 9.4000 | 3 | 3 |
quindoline | Homo sapiens (human) | IC50 | 138.0000 | 1 | 1 |
u 73122 | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
celastrol | Homo sapiens (human) | IC50 | 0.7800 | 1 | 1 |
alteichin | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
3',4'-dihydroxyflavone | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
tanshinone ii a | Homo sapiens (human) | IC50 | 2.7500 | 2 | 2 |
Telomestatin | Homo sapiens (human) | IC50 | 0.3517 | 6 | 6 |
7,8,3'-trihydroxyflavone | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one | Homo sapiens (human) | IC50 | 0.3240 | 5 | 5 |
7,8,4'-trihydroxyflavone | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
okanin | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
3',4',7-trihydroxyflavone | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
beta-rubromycin | Homo sapiens (human) | IC50 | 2.2275 | 4 | 4 |
mkt 077 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
braco-19 | Homo sapiens (human) | IC50 | 1.0883 | 6 | 6 |
bibr 1532 | Homo sapiens (human) | IC50 | 2.4824 | 12 | 12 |
n'-(10h-indolo(3,2-b)quinolin-11-yl)-n,n-dimethylpropane-1,3-diamine | Homo sapiens (human) | IC50 | 0.4775 | 4 | 4 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
braco-19 | Homo sapiens (human) | EC50 | 1.3522 | 5 | 5 |
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 26, Issue:6, 2016
Novel myricetin derivatives: Design, synthesis and anticancer activity.European journal of medicinal chemistry, , Jun-05, Volume: 97, 2015
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.European journal of medicinal chemistry, , Mar-03, Volume: 74, 2014
Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 23, Issue:3, 2013
Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.European journal of medicinal chemistry, , Volume: 51, 2012
Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.Bioorganic & medicinal chemistry letters, , May-15, Volume: 21, Issue:10, 2011
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.Bioorganic & medicinal chemistry, , Nov-15, Volume: 18, Issue:22, 2010
Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 20, Issue:19, 2010
Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.Bioorganic & medicinal chemistry letters, , Oct-22, Volume: 11, Issue:20, 2001
Recent applications of vinyl sulfone motif in drug design and discovery.European journal of medicinal chemistry, , Apr-15, Volume: 234, 2022
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.European journal of medicinal chemistry, , Jan-15, Volume: 210, 2021
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.European journal of medicinal chemistry, , Apr-13, Volume: 112, 2016
Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.European journal of medicinal chemistry, , Volume: 60, 2013
Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.Bioorganic & medicinal chemistry, , Nov-01, Volume: 20, Issue:21, 2012
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.Bioorganic & medicinal chemistry, , Nov-01, Volume: 19, Issue:21, 2011
Indoloquinolines as scaffolds for the design of potent G-quadruplex ligands.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 72, 2022
Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.European journal of medicinal chemistry, , Jan-05, Volume: 227, 2022
Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data.European journal of medicinal chemistry, , Volume: 68, 2013
N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage.Journal of medicinal chemistry, , Mar-10, Volume: 54, Issue:5, 2011
Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action.Proceedings of the National Academy of Sciences of the United States of America, , Oct-30, Volume: 104, Issue:44, 2007
Targeting telomerase with radiolabeled inhibitors.European journal of medicinal chemistry, , Jan-05, Volume: 125, 2017
A new strategy for detection and development of tractable telomerase inhibitors.Journal of medicinal chemistry, , Apr-26, Volume: 55, Issue:8, 2012
Catecholic flavonoids acting as telomerase inhibitors.Journal of medicinal chemistry, , Dec-16, Volume: 47, Issue:26, 2004
Telomere maintenance as a target for drug discovery.Journal of medicinal chemistry, , Feb-13, Volume: 57, Issue:3, 2014
A new strategy for detection and development of tractable telomerase inhibitors.Journal of medicinal chemistry, , Apr-26, Volume: 55, Issue:8, 2012
BRACO19 analog dimers with improved inhibition of telomerase and hPot 1.Bioorganic & medicinal chemistry, , Mar-01, Volume: 17, Issue:5, 2009
Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.European journal of medicinal chemistry, , Volume: 44, Issue:10, 2009
Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure.European journal of medicinal chemistry, , Volume: 44, Issue:12, 2009
Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs.Journal of medicinal chemistry, , Dec-25, Volume: 51, Issue:24, 2008
Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action.Proceedings of the National Academy of Sciences of the United States of America, , Oct-30, Volume: 104, Issue:44, 2007
Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 17, Issue:8, 2007
Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.Journal of medicinal chemistry, , Jan-26, Volume: 49, Issue:2, 2006
Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.Bioorganic & medicinal chemistry letters, , Aug-16, Volume: 14, Issue:16, 2004
Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Targeting telomerase with radiolabeled inhibitors.European journal of medicinal chemistry, , Jan-05, Volume: 125, 2017
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.European journal of medicinal chemistry, , Apr-13, Volume: 112, 2016
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Design and synthesis of celastrol derivatives as anticancer agents.European journal of medicinal chemistry, , May-05, Volume: 95, 2015
Novel myricetin derivatives: Design, synthesis and anticancer activity.European journal of medicinal chemistry, , Jun-05, Volume: 97, 2015
Telomere maintenance as a target for drug discovery.Journal of medicinal chemistry, , Feb-13, Volume: 57, Issue:3, 2014
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.European journal of medicinal chemistry, , Mar-03, Volume: 74, 2014
A new strategy for detection and development of tractable telomerase inhibitors.Journal of medicinal chemistry, , Apr-26, Volume: 55, Issue:8, 2012
Inhibition of telomerase by BIBR 1532 and related analogues.Bioorganic & medicinal chemistry letters, , Apr-07, Volume: 13, Issue:7, 2003
Indoloquinolines as scaffolds for the design of potent G-quadruplex ligands.Bioorganic & medicinal chemistry letters, , 09-15, Volume: 72, 2022
Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.European journal of medicinal chemistry, , Jan-05, Volume: 227, 2022
Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data.European journal of medicinal chemistry, , Volume: 68, 2013
5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation.Journal of medicinal chemistry, , Oct-23, Volume: 51, Issue:20, 2008
Enables
This protein enables 16 target(s):
Target | Category | Definition |
tRNA binding | molecular function | Binding to a transfer RNA. [GOC:ai] |
transcription coactivator binding | molecular function | Binding to a transcription coactivator, a protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. [GOC:krc] |
DNA binding | molecular function | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb, GOC:vw] |
telomerase activity | molecular function | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence. [GOC:krc, PMID:28732250] |
telomerase RNA reverse transcriptase activity | molecular function | Catalysis of the extension of the 3' end of a DNA strand by one deoxynucleotide at a time. Cannot initiate a chain de novo; uses the RNA subunit of the telomerase enzyme complex as its template. [EC:2.7.7.49, PMID:11812242] |
RNA binding | molecular function | Binding to an RNA molecule or a portion thereof. [GOC:jl, GOC:mah] |
RNA-directed DNA polymerase activity | molecular function | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time. [EC:2.7.7.49] |
RNA-dependent RNA polymerase activity | molecular function | Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template, i.e. the catalysis of RNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. [EC:2.7.7.48, GOC:mah, GOC:pf] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
protein homodimerization activity | molecular function | Binding to an identical protein to form a homodimer. [GOC:jl] |
metal ion binding | molecular function | Binding to a metal ion. [GOC:ai] |
protein-folding chaperone binding | molecular function | Binding to a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. [PMID:10585443] |
telomerase RNA binding | molecular function | Binding to the telomerase RNA template. [GOC:krc, PMID:16884717] |
template-free RNA nucleotidyltransferase | molecular function | Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); the addition of a terminal nucleotide to an RNA molecule in the absence of a nucleic acid template. [GOC:BHF, GOC:BHF_telomere, GOC:dos, GOC:nc, PMID:15994230] |
telomeric DNA binding | molecular function | Binding to a telomere, a specific structure at the end of a linear chromosome required for the integrity and maintenance of the end. [GOC:jl, SO:0000624] |
Located In
This protein is located in 8 target(s):
Target | Category | Definition |
chromosome, telomeric region | cellular component | The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres). [GOC:elh] |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
nucleolus | cellular component | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. [ISBN:0198506732] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
nuclear speck | cellular component | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. [http://www.cellnucleus.com/] |
mitochondrial nucleoid | cellular component | The region of a mitochondrion to which the DNA is confined. [GOC:jl] |
Part Of
This protein is part of 5 target(s):
Target | Category | Definition |
telomerase holoenzyme complex | cellular component | Telomerase is a ribonucleoprotein enzyme complex, with a minimal catalytic core composed of a catalytic reverse transcriptase subunit and an RNA subunit that provides the template for telomeric DNA addition. In vivo, the holoenzyme complex often contains additional subunits. [PMID:11884619] |
TERT-RMRP complex | cellular component | A ribonucleoprotein complex that has RNA-directed RNA polymerase (RdRP) activity, and is composed of telomerase reverse transcriptase (TERT) and the non-coding RNA component of mitochondrial RNA processing endoribonuclease (RMRP). [GOC:bf, GOC:BHF, GOC:BHF_telomere, GOC:nc, PMID:19701182] |
telomerase catalytic core complex | cellular component | The minimal catalytic core of telomerase is a ribonucleoprotein complex composed of a catalytic reverse transcriptase subunit and an RNA subunit that provides the template for telomeric DNA addition. [GOC:BHF-UCL, PMID:11884619, PMID:1808260] |
nuclear telomere cap complex | cellular component | A complex of DNA and protein located at the end of a linear chromosome in the nucleus that protects and stabilizes a linear chromosome. [GOC:elh] |
RNA-directed RNA polymerase complex | cellular component | A protein complex that possesses RNA-directed RNA polymerase activity. [GOC:mah] |
Involved In
This protein is involved in 32 target(s):
Target | Category | Definition |
telomere maintenance | biological process | Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences. [GOC:BHF, GOC:BHF_telomere, GOC:elh, GOC:rl, PMID:11092831] |
RNA-templated transcription | biological process | The synthesis of an RNA transcript from an RNA template. [GOC:txnOH] |
RNA-templated DNA biosynthetic process | biological process | A DNA biosynthetic process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strand. [GOC:mah, ISBN:0198506732] |
telomere maintenance via telomerase | biological process | The maintenance of proper telomeric length by the addition of telomeric repeats by telomerase. [GOC:elh] |
mitochondrion organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. [GOC:dph, GOC:jl, GOC:mah, GOC:sgd_curators, PMID:9786946] |
negative regulation of gene expression | biological process | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). [GOC:txnOH-2018] |
DNA strand elongation | biological process | The DNA metabolic process in which an existing DNA strand is extended by activities including the addition of nucleotides to the 3' end of the strand. [GOC:isa_complete, GOC:mah] |
positive regulation of Wnt signaling pathway | biological process | Any process that activates or increases the frequency, rate or extent of Wnt signal transduction. [GOC:dph, GOC:go_curators, GOC:tb] |
siRNA processing | biological process | A process leading to the generation of a functional small interfering RNA (siRNA). Includes the cleavage of double-stranded RNA to form small interfering RNA molecules (siRNAs) of 21-23 nucleotides. May also include amplification of the siRNA by RNA-directed RNA polymerase. [GOC:mah, PMID:11524674, PMID:19239886, PMID:20687832] |
regulation of protein stability | biological process | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. [GOC:dph, GOC:mah, GOC:tb] |
positive regulation of protein binding | biological process | Any process that activates or increases the frequency, rate or extent of protein binding. [GOC:mah] |
positive regulation of hair cycle | biological process | Any process that activates or increases the frequency, rate or extent of the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair. [GOC:go_curators, PMID:12230507] |
negative regulation of neuron apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. [GOC:go_curators, GOC:mtg_apoptosis] |
positive regulation of angiogenesis | biological process | Any process that activates or increases angiogenesis. [GOC:go_curators] |
positive regulation of glucose import | biological process | Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. [GOC:ai, GOC:dph, GOC:tb] |
response to cadmium ion | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. [GOC:ai] |
positive regulation of nitric-oxide synthase activity | biological process | Any process that activates or increases the activity of the enzyme nitric-oxide synthase. [GOC:ai] |
establishment of protein localization to telomere | biological process | The directed movement of a protein to a specific location in the telomeric region of a chromosome. [GOC:BHF, GOC:mah] |
cellular response to hypoxia | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:mah] |
DNA biosynthetic process | biological process | The biosynthetic process resulting in the formation of DNA. [GOC:mah] |
replicative senescence | biological process | A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging. [GOC:BHF] |
siRNA transcription | biological process | The transcription of a small interfering RNA from an RNA template. [PMID:23001036] |
positive regulation of G1/S transition of mitotic cell cycle | biological process | Any signaling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. [GOC:mtg_cell_cycle] |
positive regulation of miRNA transcription | biological process | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. [GO_REF:0000058, GOC:dph, GOC:kmv, GOC:TermGenie, PMID:24699545] |
positive regulation of transdifferentiation | biological process | Any process that activates or increases the frequency, rate or extent of transdifferentiation. [GO_REF:0000058, GOC:TermGenie, PMID:22118091] |
positive regulation of vascular associated smooth muscle cell proliferation | biological process | Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation. [GO_REF:0000058, GOC:TermGenie, PMID:23246467] |
positive regulation of protein localization to nucleolus | biological process | Any process that activates or increases the frequency, rate or extent of protein localization to nucleolus. [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:24415760] |
positive regulation of vascular associated smooth muscle cell migration | biological process | Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration. [GO_REF:0000058, GOC:BHF, GOC:BHF_miRNA, GOC:rph, GOC:TermGenie, PMID:20693317] |
negative regulation of endothelial cell apoptotic process | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process. [GOC:BHF, GOC:mah, GOC:mtg_apoptosis] |
positive regulation of stem cell proliferation | biological process | Any process that activates or increases the frequency, rate or extent of stem cell proliferation. [GOC:dph] |
negative regulation of cellular senescence | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence. [GOC:BHF] |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. [GOC:mtg_apoptosis] |